PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients

Completed

Conditions studied: Prostate Cancer

In brief

This registry is for men who have prostate cancer and have had multigene panel hereditary testing. The registry will gather data on genetic testing results and how that information may change physician treatment or follow up recommendations. It will also gather data on the patient's experience with genetic testing, through a post-test survey to be completed 60-90days after results have been received and discussed with their provider.

Key facts

Study ID
NCT05447637
Run by
Invitae Corporation
People needed
1000
Starts
2019-11-01
Expected to finish
2022-05-31
Last updated by the study team
2022-07-07

Who can join

Age: 18 and older, up to 90. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.